Articles tagged with Viral Infections
Immerge BioTherapeutics has identified the PERV receptor, a key factor in understanding the safety of xenotransplantation. This breakthrough allows for the development of safer porcine organs for human transplantation, addressing an unmet need in clinical transplantation.
Researchers used data on recent SARS cases to project how the epidemic will proceed under various circumstances. They found that careful interventions, such as reducing contacts and improving treatment, can control the spread of the virus.
Researchers propose pathogenic bacteria and viruses could originate from outer space, citing the unusual nature of major epidemics like SARS. The novel virus in SARS has been identified as a possible explanation for its unexpected appearance and global spread.
Researchers found green tea extract from tea bags is more effective than loose tea against human pathogenic viruses. Caffeinated green and black teas also outperform decaffeinated versions as anti-viral agents.
Researchers discovered that 29% of individuals were completely resistant to the Norwalk virus, with those lacking the FUT2 gene showing no signs of infection. The study suggests that vaccination may be effective in reducing disease burden and offers new hope for developing vaccines.
Researchers have identified two distinct genotypes of the SARS virus, linked to geographic clusters of infections. The study provides valuable insights into the genetic makeup of the virus, which could inform public health strategies and vaccine development.
A modified adenovirus, Delta-24-RGD, has shown improved infectivity and replication efficiency compared to the unmodified Delta-24. This leads to increased cytopathic effects and prolonged survival rates in mouse models of human glioma. The authors conclude that Delta-24-RGD may be an effective agent in treating gliomas.
Scientists at University of Maryland Biotechnology Institute developed a new vaccine using recombinant DNA technology to protect fish against infectious pancreatic necrosis virus. The vaccine, composed of hollow virus-like particles, demonstrates a resistance potential against the disease and has shown promising results in experiments.
Researchers identify viral protease NS3/4A as a key player in evading the immune system, leading to new avenues for clinical and basic research on hepatitis C. Inhibiting this protease restores the host's immune response, reducing viral levels to nearly undetectable levels.
A 2002 conjunctivitis outbreak at Dartmouth College revealed bacterial pinkeye caused by a strain of Streptococcus pneumoniae lacking protective capsule. Effective collaboration between doctors, health officials, and the CDC helped contain the outbreak through rapid communication and basic hygiene measures.
Researchers at St. Jude Children's Research Hospital found that an anti-flu-virus drug can protect against pneumonia by blocking the activity of flu virus enzyme neuraminidase. This protection reduces illness and incidence of death from subsequent infection by Streptococcus pneumoniae bacteria.
Researchers discovered that normal nerve cells can use IRES to produce large quantities of protein, mimicking viral behavior. This switch allows for massive production of specific proteins like ELH hormone, potentially impacting learning and memory processes in the brain.
Researchers found that B cells and antibodies are essential for controlling the infection in mice. Without them, even low doses of the virus can be deadly. The study's findings may explain why elderly people and those with weakened immunity are more likely to develop serious disease.
Research finds that forest fragmentation leads to increased blacklegged tick populations, particularly in areas with small forest fragments. This could lead to a higher risk of Lyme disease for people living nearby, as these ticks are the primary carriers of the bacteria.
Researchers uncover molecular signal critical for selective recruitment of viral RNA segments to form complete flu genome. This discovery may help develop new vaccines and antiviral drugs targeting the genetic trick used by the flu virus.
Researchers found that the absence of the SAP gene impairs the immune system's ability to recognize and react to infection, leading to impaired long-term antibody responses. The study has implications for vaccine development and may offer therapeutic benefits in treating X-linked lymphoproliferative disease.
The University of Washington has established a $9 million center to study the underlying causes of hepatitis-induced liver disease. The center brings together experts in viral hepatitis, liver disease, and transplantation to investigate gene and protein expression in liver cells.
Researchers found that a virus uses a protein called actin to destroy its own cells, allowing it to escape and infect other cells. The discovery provides new insights into viral infections and could lead to the development of antiviral agents.
NASA's Public Health Applications Program aims to provide public health agencies with innovative technologies, data, and satellite-based tools to combat the disease. The program helps identify environmental indicators, predicts disease outbreaks, and informs mosquito surveillance efforts.
A UC Berkeley study analyzed 27 clinical trials and found that combining Chinese herbal treatments with interferon alfa was 1.5-2 times more effective in reducing viral load than using interferon alfa alone. The most promising results came from patients using a combination of bufotoxin and kurorinone with interferon alfa.
A new study found that a combination of peginterferon alfa-2a and ribavirin can offer superior efficacy without increasing common side effects, particularly in patients infected with hepatitis C genotype 1. The treatment approach showed a higher sustained response rate compared to standard therapy.
Researchers have discovered a new viral structure that suggests a continuum in the evolution of viruses, revealing similarities between PRD1 and human adenoviruses. The findings provide insights into the evolutionary path taken by families of viruses and may lead to the development of new therapies for certain infections.
A study by Dr. G. Paolo Dotto and colleagues found that decreased Notch1 expression enables the increased expression of HPV viral proteins E6 and E7, promoting malignant cell transformation.
A U.Va. study is investigating the effectiveness of echinacea in treating colds by standardizing extracts from the plant. The researchers plan to recruit approximately 450 subjects and administer three different concentrations of echinacea constitutents to test their impact on viral replication and inflammatory responses.
Researchers have pinpointed the cause of hepatitis A virulence by identifying two key genes, 2C and VP1/2A. The discovery may lead to the development of a live, attenuated HAV vaccine that could be more effective and affordable for widespread use.
The American Association of Clinical Chemistry presents an update on HCV testing, highlighting the importance of laboratory tests for diagnosis and monitoring treatment efficacy. New testing methods, including core antigen and genotype testing, are being developed to assist clinicians in diagnosing HCV infection.
A study of over 1,000 passengers flying between San Francisco and Denver found that recirculated cabin air did not cause more colds than fresh air. The researchers suggest that being on a plane packed with people may be the primary factor in transmission of colds.
Researchers found that viral infections in infancy can cause long-term changes in the body's anti-viral system, leading to chronic respiratory inflammation and distress. Mice infected with paramyxoviral virus developed airway hyperreactivity and mucus-producing cells, symptoms similar to asthma.
The new treatment combines antiviral and anti-inflammatory drugs to target the root cause of cold symptoms, not just its symptoms. Researchers found that adding interferon to the treatment increased effectiveness compared to individual medications alone.
The MAP kinase pathway is activated in response to coxsackievirus infection, leading to increased viral replication. This signaling cascade also triggers host cell responses, including inflammation and immune activation.
A study found that RSV prevention in premature infants during their first winter of life can lead to better lung function and fewer respiratory issues. The treatment reduced the risk of RSV infections by 85%, resulting in fewer colds, asthma attacks, and allergies.
A study found that influenza A infection attracts pneumonia bacteria, increasing binding to lung epithelial cells. Treatment with Tamiflu may prevent this increased binding and related complications.
Researchers at UCR discovered that animal cells use RNA silencing to protect themselves from viral infections, a mechanism also found in plants. This breakthrough could lead to new gene therapies and vaccine designs for treating recalcitrant human and animal viral diseases.
The VIRAHEP-C clinical trial investigates the effectiveness of combination therapy for chronic hepatitis C, with a focus on racial disparities. Researchers hope to determine factors associated with sustained virological response rates in African-American patients, who are disproportionately affected by the disease.
A recent study published in the Pediatric Academic Societies found that low-grade cervical lesions (LSILs) tend to clear up on their own in adolescent women. The study of 187 adolescents aged 13-22 years showed that only 4% had persistent LSILs after three years, and most regressed within three months.
Researchers develop mouse model of sporadic and familial human meningioma, demonstrating NF2 loss is sufficient for tumor formation. The study provides novel insight into the role of the NF2 gene in meningioma development and enables testing of potential therapies.
A recent study found that people previously infected with HCV are 12 times less likely to develop persistent infection than those infected for the first time. This suggests that immunity can be acquired to protect against viral persistence, making vaccines a potential solution to reduce medical consequences of HCV infection.
Researchers discovered two mechanisms by which adenoviruses establish persistent infections: interfering with apoptosis signaling and preventing apoptosis through the Receptor Internalization and Degradation complex. This knowledge could improve the usefulness of adenovirus vectors in gene therapy.
A Baylor College of Medicine study found that Helicobacter pylori infection is most common among children under 10, with an estimated 24.5% infected by age 18-23. The average age of first infection was 7.5 years, and over 84% of infected children remained infected during adolescence and young adulthood.
Recent studies confirm presence of SV40 DNA in human lymphoma samples, suggesting possible vaccine-related transmission. The findings have significant implications for understanding cancer development and prevention.
Researchers at Immerge BioTherapeutics have identified miniature swine that do not transmit the pig retrovirus (PERV) to humans. The study characterizes three sub-classes of PERV A, B and C found in the herd of inbred miniature swine, showing consistent non-transmitting phenotypes.
Scientists have identified specific cells called dendritic cells that produce massive quantities of interferon quickly after a virus appears, providing a rapid response to infections. This discovery may lead to new medical applications for interferon and shed light on the body's innate immune response.
Researchers at Oregon State University have identified a new type of virus in an aborted calf, which is part of the calicivirus family that can infect various species. The discovery raises concerns about the potential spread of disease among livestock and its impact on public health.
Researchers at the University of Maryland Biotechnology Institute have identified specific amino acid residues in the Gumboro-causing viruses responsible for their infection and disease development in poultry. This discovery will enable the creation of more effective genetically engineered vaccines to protect against severe outbreaks.
A NASA-funded study utilizes satellite data on temperature and vegetation to forecast West Nile Virus transmission and identify high-risk areas. The analysis reveals that mosquito populations thrive in warmer, wetter conditions, allowing researchers to pinpoint disease hotspots and make predictions about future outbreaks.
A longitudinal study of 1791 Brazilian women found that persistent HPV infections increased the risk of squamous intraepithelial lesions (SIL) by 10.2 times compared to those without infection. Women with persistent type 16 or 18 HPV infections had a strong correlation with SIL incidence.
A study of 250 primary-care patients found that infections like glandular fever can trigger chronic fatigue syndrome (CFS), while mood disorders are predicted by factors such as psychiatric history and social adversity. Early physical activity may help prevent or treat CFS after infectious mononucleosis.
Researchers have found a new, hidden piece of the influenza virus that may kill immune system cells. This protein was discovered by accident while studying
Researchers have developed a new method for studying viral entry, which reveals that key steps occur much faster than previously believed. The study found that viruses can penetrate cells within minutes, using the cell's own transportation system to reach the nucleus.
Research found that over 34% of ventilated patients are sexually active, with better lung function and younger age being key factors. Meanwhile, a study in Ethiopia linked home kerosene use to increased allergy risk, while another study showed nearly 40% of COPD exacerbations are caused by respiratory viruses.
Researchers found a virus similar to HEV in rats in Los Angeles, which may contribute to the high rates of HEV antibodies in some inner city areas. The study suggests that infected rats could be a source of exposure for humans and highlights the need for further testing.
Yale scientists have successfully immunized mice against West Nile virus, providing a promising lead for developing a vaccine for humans. The vaccine was developed using a protein found in the virus and showed complete protection against the disease.
Researchers find that hormonal manipulation has no effect on virus responses in female rodents, suggesting genetic differences may be involved. In contrast, castrated male rats exhibit female-type responses to hantavirus infection.
Researchers found that prion diseases adapt slowly to new species through a prolonged process, making early detection difficult. The study also showed that the disease can spread rapidly in new hosts under specific conditions.
A study published in JAMA found that the misdiagnosis rate for appendicitis remained high despite the availability of new diagnostic tests, particularly among young women and older men. The researchers analyzed data from 85,790 appendectomies performed in Washington state between 1987 and 1998 and found that the rate of misdiagnosis in...
The newly detailed structure of PRD1 reveals striking similarities with human adenoviruses, suggesting a conserved icosahedral shape used by viruses across species. This knowledge may inform the development of novel antibiotic strategies against antibiotic-resistant bacteria.
A new combination drug treatment has shown to be more effective in treating chronic hepatitis C than the current standard. The treatment, peginterferon alfa-2b plus ribavirin, achieved higher sustained viral response rates compared to interferon alfa-2b plus ribavirin, especially in patients with genotype 1 infection.
A small genetic change in the PB2 gene makes influenza viruses more potent, warns of potential dangers of new strains. Research helps develop strategies for detecting future outbreaks and prepares for pandemics.
Researchers create antibody Fab D18, which blocks prion propagation and clears infectious prions from cell cultures. This breakthrough provides a potential therapeutic target for a human drug to cure established infection.
Vancouver is facing a high risk of an hepatitis A outbreak due to past infections among street youth, injection drug users, and men who have sex with men. The Canadian Medical Association Journal report highlights the need for vaccination programs to protect these groups.